Stcube (052020)

KOSDAQ
Currency in KRW
5,650
+40(+0.71%)
Closed·
052020 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
052020 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5,5005,680
52 wk Range
3,89110,470
Key Statistics
Edit
Bid/Ask
5,640.00 / 5,650.00
Prev. Close
5,610
Open
5,590
Day's Range
5,500-5,680
52 wk Range
3,891-10,470
Volume
100.01K
Average Volume (3m)
193.35K
1-Year Change
-0.96%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
052020 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
No news in this category
Looks like there are no results in this news category

Stcube Company Profile

STCube, Inc., a biopharmaceutical company, develops medicines in South Korea. The company develops anti-cancer immunotherapeutic drugs and anti-viral drugs. It offers platform technologies, which include In vivo RNAi ICP target discovery platform for exploring material ICP target; glycosylation-specific antibody development platform for development of antibodies that mask glycosylation sites on target proteins; and ICP functional assay platform for development of various in vivo/in vitro analytical/experimental methods. The company’s product pipeline consists of various anti-cancer drugs, including anti PD-L1 Ab and anti PD-1 Ab in preclinical study, and anti STT-005 for solid tumor; anti STT-003 Ab in phase-1 for lung, head, and neck cancer; small molecule STT-011 inhibitor candidate development for pancreatic cancer; anti STT-012 Ab for breast and prostate cancer; and anti STT-013 Ab for solid tumor. The company was formerly known as Schem Co., Ltd. and changed its name to STCube, Inc. in April 2008. The company was founded in 1989 and is headquartered in Seoul, South Korea.

Compare 052020 to Peers and Sector

Metrics to compare
052020
Peers
Sector
Relationship
P/E Ratio
−17.9x10.3x11.4x
PEG Ratio
−1.060.180.01
Price/Book
4.1x1.4x2.4x
Price / LTM Sales
34.0x1.3x2.0x
Upside (Analyst Target)
-6.8%25.2%
Fair Value Upside
Unlock19.0%6.5%Unlock

Earnings

Latest Release
Mar 11, 2025
EPS / Forecast
-87.68 / --
Revenue / Forecast
2.56B / --
EPS Revisions
Last 90 days

FAQ

What Is the Stcube (052020) Stock Price Today?

The Stcube stock price today is 5,650.00.

What Stock Exchange Does Stcube Trade On?

Stcube is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Stcube?

The stock symbol for Stcube is "052020."

What Is the Stcube Market Cap?

As of today, Stcube market cap is 383.82B.

What Is Stcube's Earnings Per Share (TTM)?

The Stcube EPS (TTM) is -439.18.

From a Technical Analysis Perspective, Is 052020 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.